Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Nobuhisa Ando"'
Autor:
Nobuhisa Ando, Kentaro Tanaka, Kohei Otsubo, Gouji Toyokawa, Yuki Ikematsu, Maako Ide, Yasuto Yoneshima, Eiji Iwama, Hiroyuki Inoue, Kayo Ijichi, Tetsuzo Tagawa, Yoichi Nakanishi, Isamu Okamoto
Publikováno v:
Thoracic Cancer, Vol 11, Iss 10, Pp 2830-2839 (2020)
Background Mps one binder kinase activator 1 (MOB1) is a core component of the Hippo signaling pathway and has been implicated as a tumor suppressor. Here, we evaluated the possible relationship of MOB1 expression in non‐small cell lung cancer (NSC
Externí odkaz:
https://doaj.org/article/060ff2c22887419e905a3d5dd7168eed
Autor:
Tomotsugu Takano, Keisuke Takeda, Satoshi Nakamura, Genta Akiyama, Nobuhisa Ando, Masashi Komori
Publikováno v:
Respiratory Medicine Case Reports, Vol 38, Iss , Pp 101684- (2022)
Pulmonary alveolar proteinosis (PAP) is a diffuse lung disease characterized by the accumulation of alveolar surfactants due to dysfunction of granulocyte-macrophage colony-stimulating factor-dependent cholesterol clearance. Whole-lung lavage is the
Externí odkaz:
https://doaj.org/article/09a12c25d6fa4dcd866153ac419c57a5
Publikováno v:
Respirology Case Reports, Vol 9, Iss 8, Pp n/a-n/a (2021)
Abstract Chronic eosinophilic pneumonia (CEP) is a rare disorder characterized by marked accumulation of eosinophils in lung tissues and/or bronchoalveolar lavage fluid (BALF). Patients with CEP usually respond well to corticosteroids. However, more
Externí odkaz:
https://doaj.org/article/40519e8334f346da8d2b48e382ad8f8a
Autor:
Kentaro Wakamatsu, Nobuhiko Nagata, Sanae Maki, Hisamitsu Omori, Hiroyuki Kumazoe, Kayoko Ueno, Yuko Matsunaga, Makiko Hara, Koji Takakura, Nagisa Fukumoto, Nobuhisa Ando, Mami Morishige, Takashi Akasaki, Ichiro Inoshima, Shinji Ise, Miiru Izumi, Masayuki Kawasaki
Publikováno v:
Pulmonary Medicine, Vol 2015 (2015)
Objective. This study aimed to examine the nutritional status and nutrient intake of patients with MAC lung disease with a focus on visceral fat area. Patients and Methods. Among 116 patients of our hospital with nontuberculous mycobacteriosis who we
Externí odkaz:
https://doaj.org/article/016ff487d53b4599b14358baef039dc5
Autor:
Kazuo YAMAMURA, Satoshi OHTANI, Yoshitsune HATSUKAWA, Kenta TANAKA, Shinsuke SAGA, Nobuhisa ANDO
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 83:1900-1905
Autor:
Gouji Toyokawa, Kohei Otsubo, Yasuto Yoneshima, Nobuhisa Ando, Yoichi Nakanishi, Kentaro Tanaka, Yuki Ikematsu, Kayo Ijichi, Eiji Iwama, Maako Ide, Isamu Okamoto, Tetsuzo Tagawa, Hiroyuki Inoue
Publikováno v:
Thoracic Cancer, Vol 11, Iss 10, Pp 2830-2839 (2020)
Thoracic Cancer
Thoracic Cancer
Background Mps one binder kinase activator 1 (MOB1) is a core component of the Hippo signaling pathway and has been implicated as a tumor suppressor. Here, we evaluated the possible relationship of MOB1 expression in non‐small cell lung cancer (NSC
Publikováno v:
Respirology Case Reports
Respirology Case Reports, Vol 9, Iss 8, Pp n/a-n/a (2021)
Respirology Case Reports, Vol 9, Iss 8, Pp n/a-n/a (2021)
Chronic eosinophilic pneumonia (CEP) is a rare disorder characterized by marked accumulation of eosinophils in lung tissues and/or bronchoalveolar lavage fluid (BALF). Patients with CEP usually respond well to corticosteroids. However, more than half
Autor:
Kentaro Tanaka, Yoichi Nakanishi, Yasuto Yoneshima, Yuki Ikematsu, Rie Furukawa, Nobuhisa Ando, Isamu Okamoto, Hirono Tsutsumi, Hiroyuki Inoue, Eiji Iwama, Keiichi Ota, Yoshimasa Shiraishi
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 155
Objectives Synergistic anticancer efficacy of combination treatment with immune checkpoint inhibitors (ICIs) and platinum-based chemotherapy in patients with advanced non–small cell lung cancer (NSCLC) may be attributable in part to the phenomenon
Autor:
Yoichi Nakanishi, Isamu Okamoto, Kayo Ijichi, Tetsuzo Tagawa, Yasuto Yoneshima, Hiroyuki Inoue, Nobuhisa Ando, Gouji Toyokawa, Yuki Ikematsu, Kentaro Tanaka, Eiji Iwama
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 146
Introduction Small cell lung cancer (SCLC) manifests high-grade neuroendocrine features, and the transcription factors ASCL1 and NEUROD1 play an important role in the survival and growth as well as contribute to the heterogeneity of SCLC cells. The r
Autor:
Kentaro Tanaka, Yuki Ikematsu, Nobuhisa Ando, Yoichi Nakanishi, Isamu Okamoto, Tetsuzo Tagawa, Yasuto Yoneshima, Hiroyuki Inoue, Kayo Ijichi, G. Toyokawa
Publikováno v:
Cancer Research. 80:4922-4922
Introduction:Small cell lung cancer (SCLC) exhibits high-grade neuroendocrine features and recent genomic analyses revealed that aberrant expression of bacic helix loop helix transcription factors such as neurogenic differentiation 1 (NEUROD1) as wel